Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
04/04/2025 | CALL | $90.00 | 3,016 | +2,995 | +14,261.90% |
07/18/2025 | PUT | $85.00 | 4,424 | +1,014 | +29.74% |
03/28/2025 | CALL | $94.00 | 763 | +752 | +6,836.36% |
10/17/2025 | PUT | $80.00 | 700 | +700 | |
02/21/2025 | CALL | $87.00 | 4,525 | +675 | +17.53% |
09/19/2025 | PUT | $70.00 | 1,389 | +675 | +94.54% |
02/21/2025 | CALL | $89.00 | 1,604 | -318 | -16.55% |
03/28/2025 | CALL | $89.00 | 56,201 | -452 | -0.80% |
03/21/2025 | CALL | $85.00 | 3,277 | -529 | -13.90% |
06/20/2025 | CALL | $90.00 | 1,991 | -581 | -22.59% |
03/21/2025 | CALL | $90.00 | 10,682 | -650 | -5.74% |
04/17/2025 | CALL | $90.00 | 19,777 | -718 | -3.50% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.04% | 77.07M | 8.28B |
Vanguard 500 Index Fund | 2.31% | 58.61M | 6.3B |
Fidelity 500 Index Fund | 1.09% | 27.79M | 2.99B |
SPDR S&P 500 ETF Trust | 1.08% | 27.45M | 2.95B |
iShares Core S&P 500 ETF | 0.89% | 22.63M | 2.43B |
Vanguard Index-Value Index Fund | 0.86% | 21.91M | 2.35B |
Select Sector SPDR Fund-Health Care | 0.81% | 20.59M | 2.21B |
Vanguard Specialized-Health Care Fund | 0.72% | 18.31M | 1.97B |
Vanguard Institutional Index Fund-Institutional Index Fund | 0.70% | 17.77M | 1.91B |
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 0.68% | 17.38M | 1.87B |
MERCK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK
02/22 06:15 pm
GlobeNewswire Inc.
Read moreHyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034
02/21 11:00 am
GlobeNewswire Inc.
Read moreROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
02/20 05:50 pm
GlobeNewswire Inc.
Read moreBESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment
02/20 02:00 pm
GlobeNewswire Inc.
Read moreAntibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements | DelveInsight
02/20 02:00 pm
GlobeNewswire Inc.
Read moreNorth America Leads the Beta-Glucan Boom: Market Insights & Industry Innovations
02/19 09:45 pm
GlobeNewswire Inc.
Read moreMERCK & CO., INC. (NYSE: MRK) INVESTOR ALERT: Investors With Large Losses in Merck & Co., Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
02/19 02:50 pm
GlobeNewswire Inc.
Read moreGlobal Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight
02/18 02:00 pm
GlobeNewswire Inc.
Read more3 Blue-Chip Dividend Stocks Trading at Multiyear Lows
02/13 10:30 am
The Motley Fool
Read moreRespiratory Syncytial Virus Therapeutics Market to Hit USD 4.64 Billion by 2032, Growing at a 14.5% CAGR – SNS Insider
02/13 10:00 am
GlobeNewswire Inc.
Read moreWant Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
02/13 07:35 am
The Motley Fool
Read moreMRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead the Merck Class Action Lawsuit
02/12 07:31 pm
GlobeNewswire Inc.
Read moreGilead Sciences Beats Q4 EPS Forecast
02/11 05:40 pm
The Motley Fool
Read moreNeuroregeneration Therapy Market to Surpass USD 64.8 Billion by 2034, Driven by Advancements in Regenerative Medicine and Rising Neurological Disorders | Transparency Market Research
02/11 04:48 am
GlobeNewswire Inc.
Read more2 Stocks That Could Soar Again in 2025
02/08 09:50 am
The Motley Fool
Read moreParesthesia Treatment Market Outlook: USD 8.0 Billion by 2034, Growing with an Aging Population and Rising Healthcare Expenditures | Analysis by TMR
02/07 12:39 pm
GlobeNewswire Inc.
Read moreAplastic Anemia Global Clinical Trials Review 2024 | Now Available
02/04 12:00 pm
GlobeNewswire Inc.
Read moreOrphan Designated Drugs Market Analysis: Key Trends, Players and Forecasts for Future Growth
02/03 05:52 am
GlobeNewswire Inc.
Read moreRecombinant Chemicals Market to Reach US$ 6.7 Bn by 2034, Driven by Rising Demand for Protein-Based Vaccines & Genetic Disorder Treatments – TMR Analysis
01/31 10:00 am
GlobeNewswire Inc.
Read moreUp More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?
01/30 10:15 am
The Motley Fool
Read moreSingle Use Assemblies Market Global Forecasts to 2029: Rapid Growth in Single-Use Assemblies Market Driven by Biologics and Biosimilars Demand
01/29 11:57 am
GlobeNewswire Inc.
Read morePotential Revolution in Healthcare Brewing, Powered by AI Innovation
01/29 09:04 am
Benzinga
Read moreAlopecia Treatment Market Size to Surpass USD 5.20 Billion by 2033 | Straits Research
01/27 11:55 am
GlobeNewswire Inc.
Read moreBiological Drugs Strategic Research Report 2024-2030, Profiles of 45+ Players Including Abbott Laboratories, Amgen, Baxter, Biogen, BMS, Eli Lilly and Co, GSK, Merck, Novartis, and Pfizer
01/27 11:49 am
GlobeNewswire Inc.
Read moreWhy This Beaten-Down Stock Is a Buy in 2025 and Beyond
01/27 09:45 am
The Motley Fool
Read moreMove Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
01/25 08:45 am
The Motley Fool
Read moreThese Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024
01/25 07:17 am
The Motley Fool
Read moreLipids Industry Trends and Company Analysis 2025-2033, Featuring NOF Corporation, Stepan Company, Archer Daniels Midland, Cargill, Kerry Group, BASF, Merck, Koninklijke DSM
01/24 06:55 am
GlobeNewswire Inc.
Read moreLive Cell Imaging Market Report 2025, with Competitor Profiles of Top 10+ Major Market Players
01/24 05:57 am
GlobeNewswire Inc.
Read moreCan the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?
01/21 06:34 am
The Motley Fool
Read moreIs Moderna Stock a Buy?
01/19 05:55 am
The Motley Fool
Read moreThis Vanguard ETF Has 23% of Its Portfolio Invested in Tech Stocks, but It Can Still Help You Generate Decades of Passive Income
01/17 09:45 am
The Motley Fool
Read more7MM Type 1 Diabetes Market Drug Forecast and Market Analysis 2023-2024 & 2033: Value to Reach $9.91 Billion - Synergistic Rise of Pumps, CGMs, and Ultra-rapid-acting Insulins in T1D Management
01/17 05:53 am
GlobeNewswire Inc.
Read moreGlobal Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica
01/17 04:30 am
GlobeNewswire Inc.
Read more3 Magnificent S&P 500 Dividend Stocks Down 25%, 60%, and 26% to Buy and Hold Forever
01/16 04:55 am
The Motley Fool
Read moreEvolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight
01/14 02:00 pm
GlobeNewswire Inc.
Read moreNicotine Replacement Therapies Market Forecast to Reach $7.52 Billion by 2032: Growing Shift Towards Personalised Nicotine Replacement Therapies
01/10 06:58 am
GlobeNewswire Inc.
Read moreObesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
01/09 03:12 pm
Benzinga
Read moreNUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries
01/09 11:53 am
GlobeNewswire Inc.
Read moreImmunotoxins Market Trends and Regional Business Opportunities, 2024-2034: Diphtheria Toxin-Based Immunotoxins Lead Revenue, Pseudomonas Exotoxins Show Rapid Growth Potential
01/09 05:52 am
GlobeNewswire Inc.
Read moreGlobal Poly (N-vinyl formamide) market to Worth Over US$ 633.85 Million By 2033 | Astute Analytica
01/09 04:30 am
GlobeNewswire Inc.
Read moreGrowth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry
01/08 11:55 am
GlobeNewswire Inc.
Read moreUnited States Chromatography Resin Market Competition, Forecast and Opportunities, 2029F Featuring Key Players, GE Healthcare, Merck, Thermo Fisher Scientific, Pall, and Purolite
01/03 10:50 am
GlobeNewswire Inc.
Read moreUK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
01/02 12:15 pm
Benzinga
Read more2 High-Yield Dividend Stocks to Buy Early in 2025
12/31 08:45 am
The Motley Fool
Read moreRevolutionizing Pharma: The Impact of Big Data and Technological Advances on the Pharma Industry
12/31 06:52 am
GlobeNewswire Inc.
Read more5 Undervalued Stocks Positioned for a Breakout Year in 2025
12/30 09:30 am
Investing.com
Read more